Intravenous immunoglobulin in neonatal group B streptococcal disease: Pharmacokinetic and safety studies in monkeys and humans
- 30 March 1984
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 76 (3) , 117-123
- https://doi.org/10.1016/0002-9343(84)90329-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- MODIFIED HUMAN IMMUNE SERUM GLOBULIN FOR INTRAVENOUS ADMINISTRATION: IN VITRO OPSONIC ACTIVITY AND IN VIVO PROTECTION AGAINST GROUP B STREPTOCOCCAL DISEASE IN SUCKLING RATSActa Paediatrica, 1982
- Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infectionThe Journal of Pediatrics, 1981
- EFFECT OF BLOOD-TRANSFUSIONS ON MORTALITY IN EARLY-ONSET GROUP-B STREPTOCOCCAL SEPTICÆMIAThe Lancet, 1979
- BLOOD-TRANSFUSION IN GROUP-B STREPTOCOCCAL SEPSISThe Lancet, 1978
- Perinatal Immunity to Group B -Hemolytic Streptococcus Type IaThe Journal of Infectious Diseases, 1977
- Immunity to the group B streptococci: interaction of serum and macrophages with types Ia, Ib, and Ic.The Journal of Experimental Medicine, 1976
- Hepatitis B Antibody in Conventional -GlobulinThe Journal of Infectious Diseases, 1975
- Cellular and humoral immune response to group B streptococciThe Journal of Pediatrics, 1973
- Role of tetanus antitoxin in the treatment of tetanus in childrenThe Journal of Pediatrics, 1966
- CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XI. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PROPHYLAXIS AND TREATMENT OF MEASLES 12Journal of Clinical Investigation, 1944